Articles about COVAXIN

Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension

29 Apr 2022

India
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension

The Ministry of External Affairs (MEA) on Friday denied reports that it had asked Bharat Biotech to address issues to avoid the cancellation of the World Health Organization's (WHO) emergency approval for its COVAXIN.

DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years

26 Apr 2022

India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years

In a significant move, the Drugs Controller General of India (DCGI) on Tuesday cleared two COVID-19 vaccines for use in children aged between five and 12 years.

COVAXIN likely to get approval for children above 2yrs: Report

22 Apr 2022

India
COVAXIN likely to get approval for children above 2yrs: Report

Bharat Biotech's COVID-19 vaccine, COVAXIN, is likely to get the Drugs Controller General of India's (DCGI) nod for use among children aged two to 12 years.

COVID-19: China fighting worst outbreak, UK sets new high

03 Apr 2022

World
COVID-19: China fighting worst outbreak, UK sets new high

COVID-19 is showing no indications of going away anytime soon, despite a decline in cases in most countries.

COVAXIN, Covishield will now be available in hospitals and clinics

27 Jan 2022

India
COVAXIN, Covishield will now be available in hospitals and clinics

The Drugs Controller General of India (DCGI) on Thursday granted approval for regular market sale to India's two most prevalent COVID-19 vaccines—COVAXIN and Covishield.

COVAXIN supply to be increased as teens get COVID-19 vaccines

03 Jan 2022

India
COVAXIN supply to be increased as teens get COVID-19 vaccines

Pharmaceutical firm Bharat Biotech on Monday said it plans to increase the supply of its COVID-19 vaccine COVAXIN to up to eight crore doses a month, starting February.

PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced

25 Dec 2021

India
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced

Prime Minister Narendra Modi on Saturday addressed the nation to announce that India will expand its nationwide COVID-19 vaccination program to adolescents aged 15-18 years next month.

COVAXIN found 50% effective against COVID-19 in first real-world study

24 Nov 2021

India
COVAXIN found 50% effective against COVID-19 in first real-world study

COVAXIN, India's indigenous coronavirus vaccine, is 50% effective against symptomatic COVID-19, the first real-world study of its effectiveness suggests.

UK to add COVAXIN to approved vaccines from November 22

09 Nov 2021

India
UK to add COVAXIN to approved vaccines from November 22

The government of United Kingdom has said that India's coronavirus vaccine COVAXIN will be added to its list of approved vaccines for international travelers.

COVID-19: India reports 11K new cases, 526 more deaths

07 Nov 2021

India
COVID-19: India reports 11K new cases, 526 more deaths

India on Sunday reported nearly 11,000 new COVID-19 cases with an active caseload of 1.44 lakh, the lowest in 260 days.

COVAXIN gets WHO approval for emergency use listing

03 Nov 2021

India
COVAXIN gets WHO approval for emergency use listing

The World Health Organization (WHO) on Wednesday granted Emergency Use Listing (EUL) to COVAXIN.

Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers

01 Nov 2021

World
Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers

Australia on Monday accepted India's indigenous vaccine, COVAXIN, as a "recognized" vaccine for the purpose of travel to the country.

COVAXIN under review; may get WHO recommendation in 24 hours

26 Oct 2021

India
COVAXIN under review; may get WHO recommendation in 24 hours

A technical advisory group of the World Health Organization (WHO) is reviewing data on COVAXIN and may recommend emergency use approval for the vaccine within 24 hours, an official said.

Coronavirus: India reports 14K+ new cases; vaccinations near 1 billion

20 Oct 2021

India
Coronavirus: India reports 14K+ new cases; vaccinations near 1 billion

India on Wednesday reported over 14,000 new COVID-19 cases with an active caseload of 1.78 lakh, the lowest in 229 days.

Vaccination for children can wait as trial still underway: Expert

19 Oct 2021

India
Vaccination for children can wait as trial still underway: Expert

India's top virologist Dr. Gagandeep Kang has said that there should not be any hurry to vaccinate children against COVID-19 as vaccine trials are ongoing and immunogenicity data is still awaited.

Cannot cut corners, thorough evaluation needed for COVAXIN EUL: WHO

19 Oct 2021

India
Cannot cut corners, thorough evaluation needed for COVAXIN EUL: WHO

The World Health Organization (WHO) Monday clarified the reason behind the delay in COVAXIN's emergency use listing (EUL), stating that it is expecting more information from Bharat Biotech on its COVID-19 vaccine.

COVAXIN recommended by expert panel for children aged 2-18 years

12 Oct 2021

India
COVAXIN recommended by expert panel for children aged 2-18 years

The Subject Expert Committee (SEC) on COVID-19 has recommended the approval of Bharat Biotech's COVAXIN for children aged between two and 18 years.

WHO expert panel to discuss COVAXIN approval in meet today

05 Oct 2021

India
WHO expert panel to discuss COVAXIN approval in meet today

COVAXIN, India's indigenous vaccine against the coronavirus, will likely receive the much-awaited approval from the World Health Organization (WHO) this month.

COVAXIN trial data for children aged 2-18 submitted to DCGI

03 Oct 2021

India
COVAXIN trial data for children aged 2-18 submitted to DCGI

Bharat Biotech has reportedly submitted trial data of its COVID-19 vaccine, COVAXIN, for children aged under 18 years to the Drugs and Comptroller General of India (DCGI).

Decision on EUL of COVAXIN in October, says WHO

30 Sep 2021

India
Decision on EUL of COVAXIN in October, says WHO

A decision on Bharat Biotech's submission seeking emergency use listing (EUL) for its COVID-19 vaccine COVAXIN will be made in October, the World Health Organization has said.

India administers over 1 crore COVID-19 vaccines for 5th time

28 Sep 2021

India
India administers over 1 crore COVID-19 vaccines for 5th time

India administered more than one crore coronavirus vaccine doses on Monday, taking the cumulative number of administered doses in the country to above 86 crore, according to the Union Health Ministry.

COVAXIN for children: Bharat Biotech completes Phase 2/3 trials

21 Sep 2021

India
COVAXIN for children: Bharat Biotech completes Phase 2/3 trials

Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, COVAXIN for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman, and Managing Director of Bharat Biotech International Ltd., Krishna Ella said.

Bharat Biotech awaits feedback from WHO for COVAXIN's EUL

17 Sep 2021

India
Bharat Biotech awaits feedback from WHO for COVAXIN's EUL

Bharat Biotech on Friday said it has submitted all the data pertaining to its COVID-19 vaccine COVAXIN to the World Health Organization for EUL and is awaiting feedback from the global health watchdog.

WHO nod for COVAXIN expected by September-end: Report

14 Sep 2021

India
WHO nod for COVAXIN expected by September-end: Report

NITI Aayog member Dr. VK Paul has said that India's indigenous COVID-19 vaccine COVAXIN's trial data looked promising, and the vaccine could soon get emergency-use approval from the World Health Organization (WHO) soon.

WHO seeks more data from Sputnik V makers for EUL

11 Sep 2021

World
WHO seeks more data from Sputnik V makers for EUL

The World Health Organization has sought some more data from Russia's Gamaleya National Research Institute of Epidemiology and Microbiology, developer of COVID-19 vaccine Sputnik V for according Emergency Use Listing status to the jab.

Single COVAXIN dose might be enough for those previously infected

28 Aug 2021

India
Single COVAXIN dose might be enough for those previously infected

A single dose of Bharat Biotech's COVAXIN in previously COVID-19-infected individuals elicits a similar antibody response as obtained with two doses of the vaccine in those without a previous history of the disease, according to an ICMR study.

COVID-19 vaccine for children likely by September, says ICMR-NIV chief

18 Aug 2021

India
COVID-19 vaccine for children likely by September, says ICMR-NIV chief

India will likely have a COVID-19 vaccine for children by next month, Dr. Priya Abraham said in an interview.

India's drug regulator approves study on mixing Covishield, COVAXIN jabs

11 Aug 2021

India
India's drug regulator approves study on mixing Covishield, COVAXIN jabs

The Drugs Controller General of India (DCGI) has approved a proposal to conduct a study on the mixing of Covishield and COVAXIN COVID-19 vaccines.

Mixing of Covishield, COVAXIN vaccines gives positive results: ICMR study

08 Aug 2021

India
Mixing of Covishield, COVAXIN vaccines gives positive results: ICMR study

A study conducted by the Indian Council of Medical Research (ICMR) has indicated that mixing and matching of COVID-19 vaccines Covishield and COVAXIN can yield better results.

Government expert panel recommends conducting trials on mixing Covishield, COVAXIN

30 Jul 2021

India
Government expert panel recommends conducting trials on mixing Covishield, COVAXIN

The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) has given its go-ahead for conducting clinical trials involving the mixing and matching of Covishield and COVAXIN vaccine doses.

As vaccination pace remains slow, Centre may reduce private quota

28 Jul 2021

India
As vaccination pace remains slow, Centre may reduce private quota

The Centre may soon reduce the 25% quota of COVID-19 vaccine supply for private facilities for their failure to pick up the earmarked quota.

India to miss July vaccination target over low COVAXIN supply

26 Jul 2021

India
India to miss July vaccination target over low COVAXIN supply

India will miss its target to give out over 500 million (50 crore) coronavirus vaccine shots by the end of July, mainly because of low supplies of COVAXIN, its only indigenous jab so far.

Bharat Biotech ends its Brazil agreement. What went wrong?

24 Jul 2021

India
Bharat Biotech ends its Brazil agreement. What went wrong?

Bharat Biotech on Friday announced the termination its agreement with two foreign firms for the supply of COVAXIN to Brazil.

COVID-19 vaccines for children likely by September, says AIIMS chief

24 Jul 2021

India
COVID-19 vaccines for children likely by September, says AIIMS chief

India will likely have its first coronavirus vaccine for children by September, said Dr. Randeep Guleria, the chief of Delhi's All India Institute of Medical Sciences (AIIMS).

Bharat Biotech commits to supply 500mn COVAXIN doses to Centre

23 Jul 2021

India
Bharat Biotech commits to supply 500mn COVAXIN doses to Centre

Bharat Biotech on Friday said it has committed to supply over 500 million doses of COVAXIN to the Centre under the countrywide immunization program.

Government to procure 66 crore doses of Covishield, COVAXIN

17 Jul 2021

India
Government to procure 66 crore doses of Covishield, COVAXIN

The Centre has placed an order to procure 66 crore doses of Covishield and COVAXIN to be supplied between August and December this year, at a revised price of Rs. 205 and Rs. 215 per dose, respectively, excluding taxes, official sources said.

Bharat Biotech enters contract manufacturing deal for COVAXIN drug substance

28 May 2021

India
Bharat Biotech enters contract manufacturing deal for COVAXIN drug substance

Hester Biosciences on Thursday said a memorandum of understanding (MoU) has been signed between Hyderabad-based vaccine maker Bharat Biotech and Gujarat COVID-19 Vaccine Consortium (GCVC) for contract manufacturing the drug substance for COVAXIN.

Zydus vaccine for 12-18-year-olds from September, says expert panel chief

09 Jul 2021

India
Zydus vaccine for 12-18-year-olds from September, says expert panel chief

Coronavirus vaccination for children with the Zydus Cadila vaccine will start by September, said Dr. NK Arora, the chief of National Expert Group on Vaccine Administration.

COVAXIN overall 77.8% effective in Phase-3 trial, says Bharat Biotech

03 Jul 2021

India
COVAXIN overall 77.8% effective in Phase-3 trial, says Bharat Biotech

COVAXIN, the coronavirus vaccine developed by India's Bharat Biotech, is overall 77.8 percent effective, the company said in a statement today, sharing the final analysis of its phase three trial data.

Seven EU nations, Switzerland approve India-made Covishield for 'Green Pass'

01 Jul 2021

World
Seven EU nations, Switzerland approve India-made Covishield for 'Green Pass'

The European Union's (EU) Digital COVID Certificate framework to allow easier, restriction-free movement of vaccinated travelers within European countries—excluding India-made Covishield and COVAXIN vaccines—comes into force on Thursday.

Prev
1 2 3
Next